40,995 research outputs found
Kuo-hsin Chen eye-level view, undated
No full textBlack-and-white photograph of Kuo-hsin Chen shelving books. The captions on the reverse of the image read, "Kou-hsin Chen History", "Chen Kuohsin", and "Monte." The stamp on the reverse of the image reads, "Taylor Publishing Co. JOB NUMBER 02764; PICT. NO. 6; PAGE NO. 239; THE U. OF CHATTANOOGA; CHATTANOOGA, TENN.
Kuo-hsin Chen eye-level view, undated
No full textBlack-and-white photograph of Kuo-hsin Chen shelving books. The captions on the reverse of the image read, "Kou-hsin Chen History", "Chen Kuohsin", and "Monte." The stamp on the reverse of the image reads, "Taylor Publishing Co. JOB NUMBER 02764; PICT. NO. 6; PAGE NO. 239; THE U. OF CHATTANOOGA; CHATTANOOGA, TENN.
sj-docx-1-jop-10.1177_02698811231218955 – Supplemental material for Dose of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding in older adults
No full textSupplemental material, sj-docx-1-jop-10.1177_02698811231218955 for Dose of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding in older adults by Yu-Hsien Li, Liang-Wen Hang, Chih-Hsin Muo, Sheng-Jen Chen and Pei-Chun Chen in Journal of Psychopharmacology</p
HSIN-CHIEH TANG, WEN-CHI YEH & SZU-LUNG CHEN (2013) Description of an endemic and endangered new Sympetrum species (Odonata: Libellulidae) from the subtropical area of Taiwan
No full textTang, Hsin-Chieh, Yeh, Wen-Chi, Chen, Szu-Lung (2013): HSIN-CHIEH TANG, WEN-CHI YEH & SZU-LUNG CHEN (2013) Description of an endemic and endangered new Sympetrum species (Odonata: Libellulidae) from the subtropical area of Taiwan. Zootaxa 3700 (2): 300-300, DOI: 10.11646/zootaxa.3700.2.
Supplementary_Figure_4 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
No full textSupplemental material, Supplementary_Figure_4 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology</p
Supplementary_Figure_5 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
No full textSupplemental material, Supplementary_Figure_5 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology</p
Supplementary_Figure_3 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
No full textSupplemental material, Supplementary_Figure_3 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology</p
Supplementary_figure_1_matching_process_20190416__3_ – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
No full textSupplemental material, Supplementary_figure_1_matching_process_20190416__3_ for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology</p
Supplementary_Tables_1_and_2_042819 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
No full textSupplemental material, Supplementary_Tables_1_and_2_042819 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology</p
Supplementary_Figure_2 – Supplemental material for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
No full textSupplemental material, Supplementary_Figure_2 for The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts by Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku and Ming-Ling Chang in Therapeutic Advances in Gastroenterology</p
- …
